Pulmonary manifestations in patients with POEMS syndrome: A retrospective review of 137 patients

Chest

Volumn 133, Issue 4, 2008, Pages 969-974

  Allam, Joanne Shirine ^a   Kennedy, Cassie C ^a   Aksamit, Timothy R ^a   Dispenzieri, Angela ^a  

^a Mayo Clinic   (United States)

Author keywords

Lung disease; Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin manifestations (POEMS) syndrome; Pulmonary hypertension; Respiratory muscle weakness

Indexed keywords

ADULT; AGED; ARTICLE; BREATHING MUSCLE; DIAPHRAGM DISEASE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; OVERALL SURVIVAL; PLEURA EFFUSION; POEMS SYNDROME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVAL TIME; SYMPTOM; THORAX RADIOGRAPHY;

EID: 42149156009     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1800     Document Type: Article

References (28)

1. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984; 34:712-720
2. Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature; French Study Group on POEMS Syndrome. Am J Med 1994; 97:543-553
3. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003; 101:2496-2506
4. Zhu WG, Wang Y, Zeng XJ, et al. A clinical analysis of 32 cases of POEMS syndrome. Chung-Hua Nei Ko Tsa Chih 2006; 45:108-111
5. Delalande S, Stojkovic T, Rose C, et al. Paralysie phrenique bilaterale, dysautonomie et cardiomyopathie restrictive dans un cas de syndrome POEMS. Rev Neurol (Paris) 2002; 158:737-740
6. Gomez Rodriguez F, Iriarte Garcia-Baquero LM, Grilo Reina A, et al. Tumorlets pulmonares en el sindrome POEMS. An Med Interna 1991; 8:555-558
7. Iwasaki H, Ogawa K, Yoshida II, et al. Crow-Fukase syndrome associated with pulmonary hypertension. Intern Med 1993; 32:556-560
8. Kashima M, Sasaki M, Ito T, et al. A case of bronchioloalveolar cell carcinoma with bilateral diffuse interstitial infiltrative shadow during the treatment of Takatsuki's disease. Nihon Kokyuki Gakkai Zasshi 2001; 39:399-404
9. Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med 1998; 157:907-911
10. Namekawa M, Muramatsu S, Hashimoto R, et al. A case of Crow-Fukase syndrome with respiratory failure due to bilateral diaphragmatic paralysis. Rinsho Shinkeigaku 2002; 42:635-638
11. Paciocco G, Bossone E, Erba H, et al. Reversible pulmonary hypertension in POEMS syndrome: another etiology of triggered pulmonary vasculopathy? Can J Cardiol 2000; 16:1007-1012
12. Okura H, Gohma I, Hatta K, et al. Thiamine deficiency and pulmonary hypertension in Crow-Fukase syndrome. Intern Med 1995; 34:674-675
13. Jouve P, Humbert M, Chanveheid MP, et al. POEMS syndrome-related pulmonary hypertension is steroid responsive. Respir Med 2007; 101:353-355
14. Ribadeau-Dumas S, Tillie-Leblond I, Rose C, et al. Pulmonary hypertension associated with POEMS syndrome. Eur Respir J 1996; 9:1760-1762
15. Shinde A, Matsumae H, Maruyama A, et al. A patient with Crow-Fukase syndrome associated with pulmonary plasmacytoma. Rinsho Shinkeigaku 2001; 41:121-125
16. Miller A, Thornton JC, Warshaw R, et al. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Am Rev Respir Dis 1983; 127:270-277
17. 1: prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir 1986; 22:589-597
18. Mukerjee D, Kingdon E, Vanderpump M, et al. Pathophysiological insights from a case of reversible pulmonary arterial hypertension. J R Soc Med 2003; 96:403-404
19. Niimi H, Arimura K, Jonosono M, et al. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. Intern Med 2000; 39:1101-1104
20. Helmersen DS, Fold GT, Viner SM, et al. POEMS syndrome: a clue to understanding primary pulmonary hypertension? A review of current insights into the pathogenesis of primary pulmonary hypertension. Can J Cardiol 2000; 16:975-981
21. Feinberg L, Temple D, de Marchena E, et al. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review of the literature. Crit Rev Oncog 1999; 10:293-302
22. Shiraki T, Satoh S, Sugiyama H, et al. Highly concentrated vascular endothelial growth factor in Crow-Fukase syndrome with high output heart failure: a case report. J Cardiol 2005; 45:75-80
23. Dispenzieri A, Gertz MA, Treatment options for POEMS syndrome. Expert Opin Pharmacother 2005; 6:945-953
24. Mokhlesi B, Jain M. Pulmonary manifestations of POEMS syndrome: case report and literature review. Chest 1999; 115:1740-1742
25. American Thoracic Society, European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166:518-624
26. de la Pena A, Subtil JC, Rodriguez-Rosado R, et al. Sindrome POEMS, a proposito de dos casos y revision de la literatura. An Med Interna 1996; 13:291-294
27. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004; 104:3400-3407
28. Loeb JM, Hauger PH, Carney JD, et al. Refractory ascites due to POEMS syndrome. Gastroenterology 1989; 96:247-249